A detailed history of Kbc Group Nv transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kbc Group Nv holds 3,425,960 shares of BMY stock, worth $196 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
3,425,960
Previous 5,616,327 39.0%
Holding current value
$196 Million
Previous $233 Million 24.0%
% of portfolio
0.54%
Previous 0.7%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $86.9 Million - $113 Million
-2,190,367 Reduced 39.0%
3,425,960 $177 Million
Q2 2024

Jul 17, 2024

BUY
$40.25 - $52.99 $12.9 Million - $17 Million
320,737 Added 6.06%
5,616,327 $233 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $117 Million - $133 Million
2,448,190 Added 85.98%
5,295,590 $287 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $34.7 Million - $41.3 Million
714,760 Added 33.52%
2,847,400 $146 Million
Q3 2023

Feb 15, 2024

SELL
$57.89 - $64.73 $39.2 Million - $43.8 Million
-676,743 Reduced 31.37%
1,480,249 $85.9 Million
Q2 2023

Feb 15, 2024

SELL
$63.71 - $70.74 $42.6 Million - $47.3 Million
-668,904 Reduced 23.67%
2,156,992 $138 Million
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $41.3 Million - $45.8 Million
648,053 Added 43.65%
2,132,640 $136 Million
Q1 2023

Feb 14, 2024

SELL
$65.71 - $74.53 $19.3 Million - $21.9 Million
-293,580 Reduced 16.37%
1,500,268 $104 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $87.9 Million - $99.7 Million
-1,338,039 Reduced 47.4%
1,484,587 $103 Million
Q4 2022

Feb 14, 2024

SELL
$68.48 - $81.09 $89.5 Million - $106 Million
-1,307,278 Reduced 42.15%
1,793,848 $129 Million
Q3 2022

Feb 15, 2024

SELL
$0.13 - $76.84 $2,795 - $1.65 Million
-21,504 Reduced 0.76%
2,825,896 $201 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $34,102 - $20.2 Million
-262,330 Reduced 8.5%
2,822,626 $201 Million
Q2 2022

Feb 14, 2024

BUY
$72.62 - $79.98 $5.78 Million - $6.37 Million
79,629 Added 2.64%
3,101,126 $239 Million
Q2 2022

Jul 26, 2022

BUY
$72.62 - $79.98 $4.61 Million - $5.08 Million
63,459 Added 2.1%
3,084,956 $238 Million
Q1 2022

Feb 14, 2024

BUY
$61.48 - $73.72 $16.8 Million - $20.1 Million
272,853 Added 9.93%
3,021,497 $221 Million
Q1 2022

May 06, 2022

BUY
$61.48 - $73.72 $16.8 Million - $20.1 Million
272,853 Added 9.93%
3,021,497 $221 Million
Q4 2021

Feb 14, 2024

SELL
$53.63 - $62.52 $5.3 Million - $6.17 Million
-98,756 Reduced 3.47%
2,748,644 $171 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $1.76 Million - $2.05 Million
32,810 Added 1.21%
2,748,644 $171 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $10.1 Million - $11.9 Million
170,981 Added 6.72%
2,715,834 $161 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $15.2 Million - $16.6 Million
246,049 Added 10.7%
2,544,853 $170 Million
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $6.46 Million - $7.27 Million
108,909 Added 4.97%
2,298,804 $145 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $28 Million - $31.7 Million
484,443 Added 28.41%
2,189,895 $136 Million
Q3 2020

Oct 28, 2020

BUY
$57.43 - $63.64 $10.1 Million - $11.2 Million
176,568 Added 11.55%
1,705,452 $103 Million
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $37.6 Million - $44 Million
685,861 Added 81.36%
1,528,884 $89.9 Million
Q1 2020

May 04, 2020

SELL
$46.4 - $67.43 $4.65 Million - $6.76 Million
-100,257 Reduced 10.63%
843,023 $47 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $3.41 Million - $4.44 Million
69,199 Added 7.92%
943,280 $60.5 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $37.3 Million - $44.2 Million
872,055 Added 43043.19%
874,081 $44.3 Million
Q2 2019

Dec 03, 2019

SELL
$44.62 - $49.34 $37.6 Million - $41.6 Million
-843,682 Reduced 99.76%
2,026 $92,000
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $37.6 Million - $41.6 Million
843,682 Added 41642.74%
845,708 $0
Q1 2019

Dec 03, 2019

SELL
$45.12 - $53.8 $33.2 Million - $39.5 Million
-734,718 Reduced 99.73%
2,026 $97,000
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $33.2 Million - $39.5 Million
734,718 Added 36264.46%
736,744 $0
Q4 2018

Dec 03, 2019

SELL
$48.76 - $63.23 $20.2 Million - $26.2 Million
-413,822 Reduced 99.51%
2,026 $105,000
Q4 2018

Jan 31, 2019

BUY
$48.76 - $63.23 $20.2 Million - $26.2 Million
413,822 Added 20425.57%
415,848 $21.6 Million
Q3 2018

Dec 03, 2019

SELL
$55.19 - $62.25 $22 Million - $24.8 Million
-398,357 Reduced 99.49%
2,026 $126,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $22 Million - $24.8 Million
398,357 Added 19662.24%
400,383 $0
Q2 2018

Dec 03, 2019

SELL
$50.53 - $62.98 $18.1 Million - $22.5 Million
-357,791 Reduced 99.44%
2,026 $112,000
Q2 2018

Aug 03, 2018

BUY
$50.53 - $62.98 $18.1 Million - $22.5 Million
357,791 Added 17659.97%
359,817 $0
Q1 2018

Dec 03, 2019

SELL
$59.92 - $68.98 $22.1 Million - $25.5 Million
-369,199 Reduced 99.45%
2,026 $128,000
Q1 2018

May 09, 2018

BUY
$59.92 - $68.98 $22.1 Million - $25.5 Million
369,199 Added 18223.05%
371,225 $0
Q4 2017

Dec 03, 2019

SELL
$59.94 - $65.35 $19 Million - $20.7 Million
-317,429 Reduced 99.37%
2,026 $124,000
Q4 2017

Feb 07, 2018

BUY
$59.94 - $65.35 $19 Million - $20.7 Million
317,429 Added 15667.77%
319,455 $0
Q3 2017

Dec 03, 2019

SELL
$55.23 - $63.74 $25.9 Million - $29.9 Million
-468,716 Reduced 99.57%
2,026 $129,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $25.9 Million - $29.9 Million
468,716 Added 23135.04%
470,742 $0
Q2 2017

Dec 03, 2019

BUY
N/A
2,026
2,026 $113,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.